anthranilamide has been researched along with pyrazines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catalano, C; Gaudreault, RC; Labrie, P; Lacroix, J; Lee, DK; Maddaford, SP; Rakhit, S | 1 |
| Abdelsalam, M; Barinka, C; Bülbül, EF; Erdmann, F; Fischer, MA; Ibrahim, HS; Krämer, OH; Mustafa, AM; Robaa, D; Romier, C; Schmidt, M; Schutkowski, M; Sippl, W; Sun, P; Vecchio, A; Zessin, M; Zeyen, P; Zeyn, Y | 1 |
2 other study(ies) available for anthranilamide and pyrazines
| Article | Year |
|---|---|
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Intestines; ortho-Aminobenzoates; Pyrazines; Quinolines | 2007 |
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; Molecular Docking Simulation; ortho-Aminobenzoates; Proton Magnetic Resonance Spectroscopy; Pyrazines; Pyridines | 2021 |